Qube Research & Technologies (QRT)
ABEO icon

Qube Research & Technologies (QRT)’s Abeona Therapeutics ABEO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-225,868
Closed -$1.19M – 3634
2025
Q3 		$1.19M Buy
225,868
+192,075
+568% +$1.22M ﹤0.01% 2442
2025
Q2 		$192K Sell
33,793
-66,348
-66% -$378K ﹤0.01% 2917
2025
Q1 		$477K Sell
100,141
-61,739
-38% -$336K ﹤0.01% 2562
2024
Q4 		$902K Buy
161,880
+101,199
+167% +$623K ﹤0.01% 2219
2024
Q3 		$384K Buy
60,681
+41,665
+219% +$218K ﹤0.01% 2353
2024
Q2 		$80.6K Sell
19,016
-53,782
-74% -$274K ﹤0.01% 2642
2024
Q1 		$528K Buy
72,798
+71,013
+3,978% +$450K ﹤0.01% 2510
2023
Q4 		$8.94K Buy
+1,785
New +$7.85K ﹤0.01% 3623
2021
Q3 		– Sell
-903
Closed -$35K – 2125
2021
Q2 		$35K Buy
+903
New +$36.8K ﹤0.01% 2052
2020
Q3 		– Sell
-1,358
Closed -$99K – 1613
2020
Q2 		$99K Buy
+1,358
New +$93.9K ﹤0.01% 1518

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ABEO Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Abeona Therapeutics (ABEO) in Q4 2025, closing a stake of 225,868 shares — an estimated $1.19M sold.

Qube Research & Technologies (QRT) first reported a position in ABEO in Q2 2020 and held it in 10 quarters. The position peaked at $1.19M in Q3 2025. 104 funds tracked by Wall St. Rank hold ABEO as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Abeona Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 225,868 Abeona Therapeutics shares in Q4 2025, an estimated $1.19M.
  • Qube Research & Technologies (QRT) first reported a position in Abeona Therapeutics in Q2 2020 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Abeona Therapeutics position peaked at $1.19M in Q3 2025.
  • 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.